Elisa Taìana
- Cancer Research top 5%
- Cancer-related molecular mechanisms research 14
- Hematology top 5%
- Multiple Myeloma Research and Treatments 14
-
- RNA Research and Splicing 12
- Protein Degradation and Inhibitors 6
- RNA modifications and cancer 6
- PI3K/AKT/mTOR signaling in cancer 5
- Ubiquitin and proteasome pathways 5
-
- Chronic Lymphocytic Leukemia Research 4
- Co-authors
- Antonino NeriDomenica RonchettiLuca AgnelliNicola AmodioMartina ManzoniKatia TodoertiPierfrancesco TassoneLucia Nobili
- Journals
- Scientific Reports (1 paper)International Journal of Molecular Sciences (2 papers)British Journal of Cancer (1 paper)
- Partner nations
- ItalyUnited StatesSwitzerland
In The Last Decade
Elisa Taìana
35 papers receiving 858 citations
Peers
Comparison fields: 5 of 69
- Cancer Research 451
- Hematology 202
- Molecular Biology 667
- Oncology 180
- Pathology and Forensic Medicine 73
Countries citing papers authored by Elisa Taìana
This map shows the geographic impact of Elisa Taìana's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elisa Taìana with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elisa Taìana more than expected).
Fields of papers citing papers by Elisa Taìana
This network shows the impact of papers produced by Elisa Taìana. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elisa Taìana. The network helps show where Elisa Taìana may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Elisa Taìana, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 3 | |
| 2 | 2024 | 5 | |
| 3 | 2023 | 5 | |
| 4 | 2022 | 3 | |
| 5 | 2022 | 14 | |
| 6 | 2021 | 32 | |
| 7 | 2021 | 16 | |
| 8 | 2021 | 5 | |
| 9 | 2021 | 8 | |
| 10 | 2020 | 12 | |
| 11 | 2020 | 10 | |
| 12 | 2020 | 7 | |
| 13 | 2019 | 9 | |
| 14 | 2019 | 22 | |
| 15 | 2018 | 204 | |
| 16 | 2018 | 31 | |
| 17 | 2017 | 33 | |
| 18 | 2015 | 23 | |
| 19 | 2015 | 49 | |
| 20 | 2014 | 38 |
About Elisa Taìana
Elisa Taìana is a scholar working on Hematology, Cancer Research and Molecular Biology, having authored 35 papers that have together received 862 indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (14 papers), Cancer-related molecular mechanisms research (14 papers), RNA Research and Splicing (12 papers), Protein Degradation and Inhibitors (6 papers), RNA modifications and cancer (6 papers), PI3K/AKT/mTOR signaling in cancer (5 papers), Ubiquitin and proteasome pathways (5 papers) and Chronic Lymphocytic Leukemia Research (4 papers). The work is most often cited by research in Cancer Research (451 citations), Hematology (202 citations) and Molecular Biology (667 citations). Elisa Taìana has collaborated with scholars based in Italy, United States and Switzerland. Frequent co-authors include Antonino Neri, Domenica Ronchetti, Luca Agnelli, Nicola Amodio, Martina Manzoni, Katia Todoerti, Pierfrancesco Tassone, Lucia Nobili, Nikhil C. Munshi and Maria Eugenia Gallo Cantafio. Their work appears in journals such as Scientific Reports, International Journal of Molecular Sciences and British Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.